Ranbaxy receives Paragraph IV certification notice from Watson Labs

Read more

Clariant Chemicals (India) board proposes relocation of Masterbatches plant

Read more

Better than Statins

Read more

‘’Patient adherence team spending more than doubled from 2009 to 2011’’

Read more

Ranbaxy completes 20 years in Russia

Read more

UKTI signs MoU with ABLE

Read more

Competition intensifies as pharma companies race to launch type II diabetes drugs

Read more

FIS and IMCD in distribution partnership

Read more

Avesthagen signs license agreement with AvestaDHATM

Read more

Novo Nordisk launches basal insulin for adult patients with type I and type II diabetes

Read more